{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:00:08Z","timestamp":1792598408972,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Project","award":["2017YFC0907103"],"award-info":[{"award-number":["2017YFC0907103"]}]},{"name":"Guangxi Science Foundation Funds","award":["2022GXNSFAA035623"],"award-info":[{"award-number":["2022GXNSFAA035623"]}]},{"name":"National Science Foundation Funds","award":["81960619"],"award-info":[{"award-number":["81960619"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"DOI":"10.1007\/s11306-026-02501-w","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:23:04Z","timestamp":1783779784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A machine learning approach to metabolomics identifies putative biomarker candidates and dysregulated pathways for distinguishing gout from asymptomatic hyperuricemia in the Zhuang population"],"prefix":"10.1007","volume":"22","author":[{"given":"Yuxia","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"2","key":"2501_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/BOR.0000000000000861","volume":"34","author":"Y Afinogenova","year":"2022","unstructured":"Afinogenova, Y., Danve, A., & Neogi, T. (2022). Update on gout management: What is old and what is new. Current Opinion in Rheumatology, 34(2), 118\u2013124. https:\/\/doi.org\/10.1097\/BOR.0000000000000861","journal-title":"Current Opinion in Rheumatology"},{"issue":"6","key":"2501_CR2","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s11306-015-0809-4","volume":"11","author":"Y Cai","year":"2015","unstructured":"Cai, Y., Weng, K., Guo, Y., Peng, J., & Zhu, Z. J. (2015). An integrated targeted metabolomic platform for high-throughput metabolite profiling and automated data processing. Metabolomics, 11(6), 1575\u20131586.","journal-title":"Metabolomics"},{"issue":"1","key":"2501_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3760\/cma.j.issn.1000-6699.2020.01.001","volume":"36","author":"Chinese Society of Endocrinology, C","year":"2020","unstructured":"Chinese Society of Endocrinology, Chinese Medical Association (2020). Guideline for the diagnosis and management of hyperuricemia and gout in China (2019). Chinese Journal of Endocrinology and Metabolism, 36(1), 1\u201313. https:\/\/doi.org\/10.3760\/cma.j.issn.1000-6699.2020.01.001. (In Chinese).","journal-title":"Chinese Journal of Endocrinology and Metabolism"},{"issue":"4","key":"2501_CR4","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/ptr.7681","volume":"37","author":"S Cong","year":"2023","unstructured":"Cong, S., Wang, L., Meng, Y., Cai, X., Zhang, C., Gu, Y., Ma, X., & Luo, L. (2023). Saussurea involucrata oral liquid regulates gut microbiota and serum metabolism during alleviation of collagen-induced arthritis in rats. Phytotherapy Research, 37(4), 1242\u20131259. https:\/\/doi.org\/10.1002\/ptr.7681","journal-title":"Phytotherapy Research"},{"issue":"2","key":"2501_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","volume":"22","author":"AJ Covarrubias","year":"2021","unstructured":"Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature reviews Molecular cell biology, 22(2), 119\u2013141. https:\/\/doi.org\/10.1038\/s41580-020-00313-x","journal-title":"Nature reviews Molecular cell biology"},{"issue":"11","key":"2501_CR6","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/nu10111564","volume":"10","author":"V Cruzat","year":"2018","unstructured":"Cruzat, V., Macedo Rogero, M., Noel Keane, K., Curi, R., & Newsholme, P. (2018). Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation. Nutrients, 10(11), 1564. https:\/\/doi.org\/10.3390\/nu10111564","journal-title":"Nutrients"},{"issue":"7","key":"2501_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin, M., Jacobsson, L., & Roddy, E. (2020). Global epidemiology of gout: Prevalence, incidence, treatment patterns and risk factors. Nature Reviews. Rheumatology, 16(7), 380\u2013390. https:\/\/doi.org\/10.1038\/s41584-020-0441-1","journal-title":"Nature Reviews. Rheumatology"},{"issue":"9","key":"2501_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094463","volume":"26","author":"A Dettlaff-Pokora","year":"2025","unstructured":"Dettlaff-Pokora, A., & Swierczynski, J. (2025). High concentrations of circulating 2PY and 4PY-potential risk factor of cardiovascular disease in patients with chronic kidney disease. International Journal of Molecular Sciences, 26(9), Article 4463. https:\/\/doi.org\/10.3390\/ijms26094463","journal-title":"International Journal of Molecular Sciences"},{"key":"2501_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1348456","volume":"11","author":"A Feraco","year":"2024","unstructured":"Feraco, A., Armani, A., Amoah, I., Guseva, E., Camajani, E., Gorini, S., Strollo, R., Padua, E., Caprio, M., & Lombardo, M. (2024). Assessing gender differences in food preferences and physical activity: A population-based survey. Frontiers in Nutrition, 11, Article 1348456. https:\/\/doi.org\/10.3389\/fnut.2024.1348456","journal-title":"Frontiers in Nutrition"},{"issue":"2","key":"2501_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/cei\/uxab021","volume":"208","author":"MM Hanlon","year":"2022","unstructured":"Hanlon, M. M., Canavan, M., Barker, B. E., & Fearon, U. (2022). Metabolites as drivers and targets in rheumatoid arthritis. Clinical and Experimental Immunology, 208(2), 167\u2013180. https:\/\/doi.org\/10.1093\/cei\/uxab021","journal-title":"Clinical and Experimental Immunology"},{"issue":"1","key":"2501_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12958-021-00748-7","volume":"19","author":"J Hu","year":"2021","unstructured":"Hu, J., Xu, W., Yang, H., & Mu, L. (2021). Uric acid participating in female reproductive disorders: A review. Reproductive Biology and Endocrinology, 19(1), 65. https:\/\/doi.org\/10.1186\/s12958-021-00748-7","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"5","key":"2501_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.tcb.2020.02.005","volume":"30","author":"K Kurmi","year":"2020","unstructured":"Kurmi, K., & Haigis, M. C. (2020). Nitrogen metabolism in cancer and immunity. Trends in Cell Biology, 30(5), 408\u2013424. https:\/\/doi.org\/10.1016\/j.tcb.2020.02.005","journal-title":"Trends in Cell Biology"},{"issue":"11","key":"2501_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3390\/toxins8110339","volume":"8","author":"A Lenglet","year":"2016","unstructured":"Lenglet, A., Liabeuf, S., Bodeau, S., Louvet, L., Mary, A., Boullier, A., Lemaire-Hurtel, A. S., Jonet, A., Sonnet, P., Kamel, S., & Massy, Z. A. (2016). N-methyl-2-pyridone-5-carboxamide (2PY)-major metabolite of nicotinamide: An update on an old uremic toxin. Toxins, 8(11), 339. https:\/\/doi.org\/10.3390\/toxins8110339","journal-title":"Toxins"},{"key":"2501_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1527716","volume":"12","author":"M Li","year":"2025","unstructured":"Li, M., Nie, Q., Xia, Q., & Jiang, Z. (2025). Assessing cross-national inequalities and predictive trends in gout burden: A global perspective (1990\u20132021). Frontiers in Medicine, 12, Article 1527716. https:\/\/doi.org\/10.3389\/fmed.2025.1527716","journal-title":"Frontiers in Medicine"},{"issue":"14","key":"2501_CR15","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.3390\/nu15143143","volume":"15","author":"Y Li","year":"2023","unstructured":"Li, Y., Han, X., Tong, J., Wang, Y., Liu, X., Liao, Z., Jiang, M., & Zhao, H. (2023). Analysis of Metabolites in Gout: A Systematic Review and Meta-Analysis. Nutrients, 15(14), 3143. https:\/\/doi.org\/10.3390\/nu15143143","journal-title":"Nutrients"},{"issue":"1","key":"2501_CR16","doi-asserted-by":"publisher","first-page":"1874652","DOI":"10.1080\/16549716.2021.1874652","volume":"14","author":"Y Li","year":"2021","unstructured":"Li, Y., Shen, Z., Zhu, B., Zhang, H., Zhang, X., & Ding, X. (2021). Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: A systematic review and meta-analysis. Global Health Action, 14(1), 1874652. https:\/\/doi.org\/10.1080\/16549716.2021.1874652","journal-title":"Global Health Action"},{"issue":"1","key":"2501_CR17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1186\/s13018-023-04240-3","volume":"18","author":"S Liu","year":"2023","unstructured":"Liu, S., Liu, Y., Wu, X., & Liu, Z. (2023). Metabolomic analysis for asymptomatic hyperuricemia and gout based on a combination of dried blood spot sampling and mass spectrometry technology. Journal of orthopaedic surgery and research, 18(1), 769. https:\/\/doi.org\/10.1186\/s13018-023-04240-3","journal-title":"Journal of orthopaedic surgery and research"},{"issue":"6","key":"2501_CR18","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1093\/rheumatology\/keab743","volume":"61","author":"S Liu","year":"2022","unstructured":"Liu, S., Wang, Y., Liu, H., Xu, T., Wang, M. J., Lu, J., Guo, Y., Chen, W., Ke, M., Zhou, G., Lu, Y., Chen, P., & Zhou, W. (2022). Serum lipidomics reveals distinct metabolic profiles for asymptomatic hyperuricemic and gout patients. Rheumatology (Oxford England), 61(6), 2644\u20132651. https:\/\/doi.org\/10.1093\/rheumatology\/keab743","journal-title":"Rheumatology (Oxford England)"},{"issue":"1","key":"2501_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1017\/S0029665122002749","volume":"82","author":"P Newsholme","year":"2023","unstructured":"Newsholme, P., Diniz, V. L. S., Dodd, G. T., & Cruzat, V. (2023). Glutamine metabolism and optimal immune and CNS function. Proceedings of the Nutrition Society, 82(1), 22\u201331. https:\/\/doi.org\/10.1017\/S0029665122002749","journal-title":"Proceedings of the Nutrition Society"},{"issue":"11","key":"2501_CR20","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1080\/09168451.2016.1210499","volume":"80","author":"T Sato","year":"2016","unstructured":"Sato, T., Ito, Y., & Nagasawa, T. (2016). Regulatory effects of the L-lysine metabolites, L-2-aminoadipic acid and L-pipecolic acid, on protein turnover in C2C12 myotubes. Bioscience biotechnology and biochemistry, 80(11), 2168\u20132175. https:\/\/doi.org\/10.1080\/09168451.2016.1210499","journal-title":"Bioscience biotechnology and biochemistry"},{"issue":"9","key":"2501_CR21","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/art.41733","volume":"73","author":"X Shen","year":"2021","unstructured":"Shen, X., Wang, C., Liang, N., Liu, Z., Li, X., Zhu, Z. J., Merriman, T. R., Dalbeth, N., Terkeltaub, R., Li, C., & Yin, H. (2021). Serum metabolomics identifies dysregulated pathways and potential metabolic biomarkers for hyperuricemia and gout. Arthritis & Rheumatology (Hoboken N J), 73(9), 1738\u20131748. https:\/\/doi.org\/10.1002\/art.41733","journal-title":"Arthritis & Rheumatology (Hoboken N J)"},{"issue":"10","key":"2501_CR22","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.5551\/jat.ED235","volume":"30","author":"M Shimabukuro","year":"2023","unstructured":"Shimabukuro, M. (2023). L-Arginine, nitric oxide, and endothelial dysfunction underlying atherosclerotic cardiovascular disease (ASCVD). Journal of atherosclerosis and thrombosis, 30(10), 1311\u20131312. https:\/\/doi.org\/10.5551\/jat.ED235","journal-title":"Journal of atherosclerosis and thrombosis"},{"issue":"19","key":"2501_CR23","doi-asserted-by":"publisher","first-page":"10840","DOI":"10.3390\/app151910840","volume":"15","author":"MA Stachelska","year":"2025","unstructured":"Stachelska, M. A., Karpi\u0144ski, P., & Kruszewski, B. (2025). A comprehensive review of biological properties of flavonoids and their role in the prevention of metabolic, cancer and neurodegenerative diseases. Applied Sciences, 15(19), 10840. https:\/\/doi.org\/10.3390\/app151910840","journal-title":"Applied Sciences"},{"issue":"3","key":"2501_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","volume":"3","author":"LW Sumner","year":"2007","unstructured":"Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., Fan, T. W., Fiehn, O., Goodacre, R., Griffin, J. L., Hankemeier, T., Hardy, N., Harnly, J., Higashi, R., Kopka, J., Lane, A. N., Lindon, J. C., Marriott, P., Nicholls, A. W., \u2026 Viant, M. R. (2007). Proposed minimum reporting standards for chemical analysis chemical analysis working group (CAWG) metabolomics standards initiative (MSI). Metabolomics, 3(3), 211\u2013221. https:\/\/doi.org\/10.1007\/s11306-007-0082-2","journal-title":"Metabolomics"},{"issue":"2","key":"2501_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.berh.2004.01.001","volume":"18","author":"J V\u00e1zquez-Mellado","year":"2004","unstructured":"V\u00e1zquez-Mellado, J., Alvarez Hern\u00e1ndez, E., & Burgos-Vargas, R. (2004). Primary prevention in rheumatology: The importance of hyperuricemia. Best practice & research. Clinical rheumatology, 18(2), 111\u2013124. https:\/\/doi.org\/10.1016\/j.berh.2004.01.001","journal-title":"Clinical rheumatology"},{"key":"2501_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.919181","volume":"13","author":"H Xu","year":"2022","unstructured":"Xu, H., Pan, L.-B., Yu, H., Han, P., Fu, J., Zhang, Z.-W., Hu, J.-C., Yang, X.-Y., Keranmu, A., Zhang, H.-J., Bu, M.-M., Jiang, J.-D., & Wang, Y. (2022). Gut microbiota-derived metabolites in inflammatory diseases based on targeted metabolomics. Front. Pharmacol., 13, Article 919181. https:\/\/doi.org\/10.3389\/fphar.2022.919181","journal-title":"Front. Pharmacol."},{"key":"2501_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1422470","volume":"15","author":"C Zhang","year":"2024","unstructured":"Zhang, C., Qian, H., Cui, Y., Li, X., Cheng, Y., & Gao, L. (2024). Associations between estradiol and hyperuricemia and the mediating effects of TC, TG, and TyG: NHANES 2013\u20132016. Front. Endocrinol., 15, Article 1422470. https:\/\/doi.org\/10.3389\/fendo.2024.1422470","journal-title":"Front. Endocrinol."},{"key":"2501_CR28","doi-asserted-by":"publisher","first-page":"791983","DOI":"10.3389\/fimmu.2021.791983","volume":"12","author":"M Zhang","year":"2022","unstructured":"Zhang, M., Zhu, X., Wu, J., Huang, Z., Zhao, Z., Zhang, X., Xue, Y., Wan, W., Li, C., Zhang, W., Wang, L., Zhou, M., Zou, H., & Wang, L. (2022). Prevalence of hyperuricemia among Chinese adults: Findings from two nationally representative cross-sectional surveys in 2015-16 and 2018-19. Frontiers in immunology, 12, 791983. https:\/\/doi.org\/10.3389\/fimmu.2021.791983","journal-title":"Frontiers in immunology"},{"issue":"1","key":"2501_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13075-018-1600-5","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Zhang, H., Chang, D., Guo, F., Pan, H., & Yang, Y. (2018). Metabolomics approach by 1H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout. Arthritis research & therapy, 20(1), 111. https:\/\/doi.org\/10.1186\/s13075-018-1600-5","journal-title":"Arthritis research & therapy"},{"issue":"23","key":"2501_CR30","doi-asserted-by":"publisher","first-page":"16040","DOI":"10.3390\/ijerph192316040","volume":"19","author":"L Zhong","year":"2022","unstructured":"Zhong, L., Liu, S., Qiu, X., Zeng, X., Su, L., Huang, D., Guo, X., Liang, J., Yang, Y., Tang, X., & Xie, Y. (2022). High prevalence of hyperuricemia and associated factors among Zhuang adults: A cross-sectional study based on the ethnic minority population cohort in the Southwestern China. International journal of environmental research and public health, 19(23), 16040. https:\/\/doi.org\/10.3390\/ijerph192316040","journal-title":"International journal of environmental research and public health"},{"issue":"9","key":"2501_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15090580","volume":"15","author":"G Zhu","year":"2025","unstructured":"Zhu, G., Luo, Y., Su, N., Zheng, X., Mei, Z., Ye, Q., Peng, J., An, P., Song, Y., Luo, W., Li, H., Wang, G., & Zhang, H. (2025). Urine metabolomics of gout reveals the dynamic reprogramming and non-invasive biomarkers of disease progression. Metabolites, 15(9), Article 580. https:\/\/doi.org\/10.3390\/metabo15090580","journal-title":"Metabolites"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02501-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-026-02501-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02501-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:20:25Z","timestamp":1788459625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-026-02501-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2501"],"URL":"https:\/\/doi.org\/10.1007\/s11306-026-02501-w","relation":{},"ISSN":["1573-3890"],"issn-type":[{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"5 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Guangxi Medical University (ID: 20170206-1). The study was conducted according to current guidelines and regulations. The research adhered to the guidelines stipulated by the World Medical Association Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"124"}}